Employer record · Boston, MA · FY2025–FY2025

Axonis Therapeutics, Inc.

    Certified LCAs
    4
    FY2024–FY2026
    USCIS approvals
    3
    3 new employment
    Denial rate
    0.0%
    FY2024–FY2026
    Median wage offered
    $135k
    certified LCAs

    Jobs not indexed yet

    Does Axonis Therapeutics, Inc. sponsor H-1B visas?

    Yes — by its record, Axonis Therapeutics, Inc. is a small-scale H-1B sponsor: it filed 4 certified Labor Condition Applications (LCAs) in FY2024–FY2026 and received 3 USCIS H-1B petition approvals (3 for new employment). Its latest certified LCA in our data was decided Jun 3, 2025. Past filings are history, not a promise: they do not mean the employer will sponsor you or a given role.

    Updated · DOL OFLC LCA disclosure + USCIS H-1B Employer Data Hub

    Filings by fiscal year

    Certified LCAs per U.S. government fiscal year (Oct–Sep); the slim bar is USCIS petition approvals (new + continuing), the bottom row their approval rate.

    Axonis Therapeutics, Inc. certified LCAs by fiscal year
    Fiscal yearcertified LCAsUSCIS approvalsApproval rate
    FY2541100%
    FY2602100%

    Occupations sponsored

    Occupation (SOC)LCAsMedian wage
    Medical Scientists, Except Epidemiologists 19-10423$130k
    Natural Sciences Managers 11-91211$175k

    Most-filed job titles

    1. Scientist, Electrophysiology2$135k
    2. Director, Chief of Staff Research and Development1$175k
    3. Senior Research Associate1$91k

    LCAs per title and median wage offered.

    Where the jobs were

    1. Massachusetts4 LCAs

    We haven't indexed Axonis Therapeutics' jobs yet

    We read jobs straight from employers' own career sites and haven't added Axonis Therapeutics' yet. Its H-1B record on this page comes from public DOL and USCIS data and is not affected.

    Also filed as

    • Axonis Therapeutics, Inc. (LCA)
    • AXONIS THERAPEUTICS INC (USCIS)

    Axonis Therapeutics, Inc. H-1B: questions people ask

    Does Axonis Therapeutics, Inc. sponsor H-1B visas?

    Yes — by its record, Axonis Therapeutics, Inc. is a small-scale H-1B sponsor: it filed 4 certified Labor Condition Applications (LCAs) in FY2024–FY2026 and received 3 USCIS H-1B petition approvals (3 for new employment). Its latest certified LCA in our data was decided Jun 3, 2025. Past filings are history, not a promise: they do not mean the employer will sponsor you or a given role.

    Is Axonis Therapeutics, Inc. still sponsoring H-1B in 2026?

    Axonis Therapeutics, Inc. had 0 certified LCAs in FY2026 (Oct 2025–Sep 2026), fewer than the 4 in FY2025. The latest one in our data was decided Jun 3, 2025. An LCA is filed before a petition, so it shows recent intent to hire on H-1B, not a hire.

    How many H-1B petitions does Axonis Therapeutics, Inc. get approved?

    USCIS recorded 3 approvals (3 for new employment, the rest continuing employment such as extensions and transfers) and 0 denials for Axonis Therapeutics, Inc. in FY2024–FY2026 — a denial rate of 0.0%. Source: USCIS H-1B Employer Data Hub (first decisions).

    What is the H-1B salary at Axonis Therapeutics, Inc.?

    The median wage offered on Axonis Therapeutics, Inc.'s certified LCAs in FY2024–FY2026 was $135k a year. By job title: Scientist, Electrophysiology $135k (2 LCAs), Director, Chief of Staff Research and Development $175k (1 LCAs) and Senior Research Associate $91k (1 LCAs). LCA wages are the pay the employer attested to; actual pay can be higher.

    Which jobs does Axonis Therapeutics, Inc. sponsor for H-1B?

    Its certified LCAs in FY2024–FY2026 were mostly for Medical Scientists, Except Epidemiologists (3) and Natural Sciences Managers (1).

    Where are Axonis Therapeutics, Inc.'s H-1B jobs?

    By worksite on its certified LCAs (FY2024–FY2026): Massachusetts (4).

    Is Axonis Therapeutics, Inc. an H-1B dependent employer?

    No — its recent LCAs do not declare it H-1B dependent.

    Does Axonis Therapeutics, Inc. have open jobs?

    We read jobs straight from employers' own career sites and haven't added Axonis Therapeutics' yet.